Melanoma Research, 0960-8931

Journal

Related Publications
  1. Reactive oxygen species in melanoma and its therapeutic implications

    Wittgen, H. G. M. & van Kempen, L. C. L. T., Dec-2007, In : Melanoma Research. 17, 6, p. 400-409 10 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

  2. Keratinocytes drive melanoma invasion in a reconstructed skin model

    Van Kilsdonk, J. W. J., Bergers, M., Van Kempen, L. C. L. T., Schalkwijk, J. & Swart, G. W. M., 2010, In : Melanoma Research. 20, 5, p. 372-80 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Dabrafenib plus trametinib is effective in the treatment of BRAF V600-mutated metastatic melanoma patients: analysis of patients from the dabrafenib plus trametinib Named Patient Program (DESCRIBE II)

    Atkinson, V., Sandhu, S., Hospers, G., Long, G. V., Aglietta, M., Ferrucci, P. F., Tulyte, S., Cappellini, G. C. A., Soriano, V., Ali, S., Poprach, A., Cesas, A., Rodriguez-Abreu, D., Lau, M., de Jong, E., Legenne, P., Stein, D., King, B. & van Thienen, J. V., Jun-2020, In : Melanoma Research. 30, 3, p. 261-267 7 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Vemurafenib in BRAF-mutant metastatic melanoma patients in real-world clinical practice: prognostic factors associated with clinical outcomes

    Schouwenburg, M. G., Jochems, A., Leeneman, B., Franken, M. G., van den Eertwegh, A. J. M., Haanen, J. B. A. G., van Zeijl, M. C. T., Aarts, M. J., van Akkooi, A. C. J., van den Berkmortel, F. W. P. J., Blokx, W. A. M., de Groot, J. W. B., Hospers, G. A. P., Kapiteijn, E., Koornstra, R. H., Kruit, W. H., Louwman, M. W. J., Piersma, D., van Rijn, R. S., Suijkerbuijk, K. P. M., ten Tije, A. J., Vreugdenhil, G., Wouters, M. W. J. M. & van der Hoeven, J. J. M., Aug-2018, In : Melanoma Research. 28, 4, p. 326-332 7 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (12) »

ID: 2651618